Diversion Control Division, US Department of Justice, Drug Enforcement Administration

ABOUT US

ABOUT US

The mission of DEA's Diversion Control Division is to prevent, detect, and investigate the diversion of controlled pharmaceuticals and listed chemicals from legitimate sources while ensuring an adequate and uninterrupted supply for legitimate medical, commercial, and scientific needs.

Program Description

Contact Us

Diversion Control Division (DEA Headquarters)

Find Your Local Diversion Field Office

Contact Local Registration Specialist

Mailing Addresses for Topics Related to Title 21 Code of Federal Regulations

Submit a Tip to DEA

Tactical Diversion Squads

Customer Service Plan (January 2010)

COVID-19 Information

Emergency Disaster Relief

Meetings & Events

Privacy Notice

What's New


REGISTRATION CALL CENTER / DIVERSION SERVICE CENTER 1-800-882-9539 or DEA.Registration.Help@dea.gov
ARCOS Reporting, CSA, Registration Applications, Changes to Name, Address, and/or Schedules, Fee Exempt, CMEA, Data-Waived Physicians, Mid-Level Practitioners To better serve your needs, please include the following information:

Subject Line:

Brief Description Title (i.e., Address Changes, CMEA, Renewal Applications, New Applications, etc.)
Body:

Describe the reason for your email. Include your contact information.

DIVERSION WEBSITE ASSISTANCE HELP DESK DEADiversionWebmaster@dea.gov
CSOS, Drug Theft Loss (DTL), Technical Website Issues.
Tell us what you think about our website and/or our online forms.
Comments and suggestions are welcomed.
To better serve your needs, please include the following information:

Subject Line:

Brief Description Title (i.e., website issues, comments, DTL, etc.)
Body:

Describe the reason for your email. Include your contact information.

ELECTRONIC PRESCRIPTIONS FOR CONTROLLED SUBSTANCES EPCS@dea.gov
The regulations provide pharmacies, hospitals, and practitioners with the ability to use modern technology for controlled substance prescriptions while maintaining the closed system of controls on controlled substances.  

DRUG & CHEMICAL EVALUATION SECTION 571-362-3249
Drug & Chemical Information, Scheduling Actions, Exempted Lists DPE@dea.gov
Bulk Chemical Manufacturer Reports BCMReports@dea.gov
National Forensic Laboratory Information System NFLIS@dea.gov

REGULATORY SECTION (For general regulatory questions, please contact
your Local Diversion Field Office.)
571-362-3314
Import/Export Permits and Declarations (Controlled Substances) CSIMEX@dea.gov
Import/Export Permits and Declarations (Chemical) Chemical.IMEX@dea.gov
ITDS - International Trade Data System ITDS@dea.gov
Mail Order Distribution Reports Mail-Ordersales@dea.gov
Medical Missions Medical.Mission@dea.gov
Natural Disasters Natural.Disaster@dea.gov
Tablet Encapsule Machine Tablet-EncapsuleMachine@dea.gov
Transshipment of Controlled Substances Transshipment@dea.gov

LIAISON SECTION 571-362-3260
Conferences, Publications, and Customer Service Plan ODLL@dea.gov

POLICY SECTION 571-362-3260
For interpretation and guidance on DEA policies and regulations ODLP@dea.gov
DEA Policy Questions should be sent in writing DEA Diversion Control Division
Attn: Policy Section
8701 Morrissette Drive
Springfield, VA 22152

PHARMACEUTICAL INVESTIGATIONS SECTION 571-362-1720
Retail Summary Reports Targeting&Analysis@dea.gov
Online Reporting: Extortion Scam, RX Abuse, Suspicious Pharmacies Submit a Tip to DEA

CHEMICAL INVESTIGATIONS SECTION 571-362-3352 or DOC@dea.gov

UN REPORTING AND QUOTA SECTION DRQ Phone Number: 571-362-3248
DRQ Fax number: 571-362-3998
Quota Applications, Year-End Reports DEAQuotas@dea.gov
Emergency Disaster Relief
Search for Year Round Pharmaceutical Disposal Locations.
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility